PTSD is a chronic psychiatric condition that can develop after traumatic experience, marked by intrusive re-experiencing, hyperarousal and enduring avoidance. Despite decades of clinical work, the underlying neurobiology remains incompletely understood, and existing interventions often deliver limited relief. Growing evidence points to the extended amygdala, and particularly the BNST, as central to the transition from acute, short-lived fear to the prolonged, sustained threat responses that define the disorder. Unlike the amygdala proper, which specializes in phasic fear, the BNST is preferentially recruited by uncertain, sustained and anticipatory threat, making it an especially relevant target for studying trauma that lingers.

The ovBNST is a small, discrete compartment within the anterolateral BNST complex, and it receives a strong and anatomically defined input from the posterior basolateral amygdala (pBLA), a region that integrates socially and emotionally salient contextual information. In the new work, the researchers combined viral tracing with RNAscope single-molecule in situ hybridization to characterize this pathway. They found that roughly 77 percent of pBLA neurons projecting to the ovBNST express the gene encoding the cannabinoid type-1 receptor (CB1R), the presynaptic receptor through which endocannabinoids exert their inhibitory effects. Moreover, about 92 percent of these projecting neurons were glutamatergic, meaning the pathway delivers excitatory signals that endocannabinoids are positioned to dial down.

To model PTSD, the team developed a modified five-day chronic social defeat stress (CSDS) paradigm in which mice are repeatedly exposed to aggressive CD-1 residents. Stressed mice subsequently avoided unfamiliar mice, spent most of their time huddled in corners away from social targets, showed reduced exploration of open and central spaces in anxiety tests, and displayed anhedonia and despair-like behaviors in sucrose preference and forced swim assays. Notably, the shortened five-day protocol induced social avoidance more efficiently than the conventional ten-day version, and it produced comparable behavioral changes in female mice, strengthening the model’s relevance.

In vivo fiber photometry revealed that ovBNST neurons are robustly activated by both acute defeat and chronic stress, and that stressed animals show exaggerated ovBNST responses upon re-encountering an aggressor. Whole-cell electrophysiology in brain slices uncovered the synaptic correlate: miniature excitatory postsynaptic current frequency was elevated after CSDS while amplitude was unchanged, indicating increased presynaptic glutamate release. Critically, blocking CB1Rs with the antagonist AM251 increased excitatory drive in both stressed and control neurons, but the effect was markedly smaller in stressed tissue, showing that the endogenous cannabinoid-mediated restraint on excitatory transmission had been substantially weakened by chronic stress.

At the molecular level, chronic stress reduced Cnr1 mRNA in the pBLA, cutting the proportion of positive neurons from 9.1 to 4.2 percent, and lowered CB1R protein in the ovBNST by about 28 percent. Using a genetically encoded fluorescent sensor called eCB2.0, the researchers directly visualized endocannabinoid release from pBLA terminals in the ovBNST in real time. Acute social defeat triggered a sustained endocannabinoid surge lasting more than fifty seconds, and after chronic stress, subsequent social re-exposure evoked an even larger release. Together, these data suggest the system tries to compensate: postsynaptic neurons pump out more endocannabinoid, but the presynaptic receptors that should receive the signal are disappearing.

The causal tests were striking. Infusing JZL195, which blocks the enzymes that degrade both major endocannabinoids, directly into the ovBNST before behavioral testing normalized social approach, restored anxiety-like measures, and rescued the shortened duration of individual social interactions in stressed mice. A more selective inhibitor, JZL184, which targets MAGL and thereby preserves the abundant endocannabinoid 2-arachidonoylglycerol (2-AG), produced the same benefits. Strikingly, systemic administration of JZL184, which acts throughout the brain, gave minimal improvement, underscoring that the therapeutic effect depends on acting within the right circuit rather than globally amplifying cannabinoid signaling.

The team then went further with projection-specific tools. Using optoCB1R, a light-activated version of the cannabinoid receptor expressed selectively in pBLA neurons, they showed that shining light onto pBLA terminals in the ovBNST during trauma re-exposure pushed stressed mice back to control-level performance, with social interaction ratios exceeding 1.2 and doubled social engagement. Conversely, using a Cre-dependent CRISPR-Cas9 strategy to knock down Dagla, the gene encoding the 2-AG synthesis enzyme DAGLα, only in ovBNST cells innervated by pBLA inputs made mice more vulnerable: under a truncated three-day stress regimen that normally causes no symptoms, DAGLα-depleted mice developed social avoidance and anxiety-like behavior. The knockdown reduced Dagla mRNA to 22 percent of control levels and had no behavioral effect in unstressed animals, confirming the interaction with stress exposure.

The mechanistic picture that emerges is one of a negative feedback loop turned pathological. During acute social threat, postsynaptic ovBNST neurons release 2-AG, which travels backward across the synapse to activate presynaptic CB1Rs on glutamatergic pBLA terminals, dampening further excitation and preventing overgeneralization of threat. With chronic stress, sustained endocannabinoid demand and receptor downregulation dismantle this brake, allowing recurrent amygdala excitation to drive pathological ovBNST hyperactivity, which manifests behaviorally as persistent avoidance and anxiety. This explains why human PET studies of CB1R availability in PTSD have yielded seemingly contradictory results, since receptor changes are region- and symptom-dependent rather than uniform across the brain.

Therapeutically, the work argues for circuit-targeted rather than systemic cannabinoid modulation. Broad CB1R activation carries known risks of cognitive and motor impairment and receptor desensitization, whereas restoring signaling only where it has failed could minimize off-target effects. The authors also caution that important questions remain: the mouse model captures behavioral dimensions rather than the full diagnostic syndrome, the eCB2.0 sensor cannot distinguish 2-AG from anandamide, and PTSD prevalence, BNST organization and endocannabinoid function all differ by sex, while the full circuit-level analysis was performed mainly in males. Still, by identifying a discrete synapse where the brain’s native cannabis-like chemistry gates the persistence of trauma-like states, the study offers a concrete, testable target for the next generation of PTSD treatments.

Subject of Research: Endocannabinoid signaling in the oval bed nucleus of the stria terminalis and PTSD-like behaviors in mice

Article Title: The oval bed nucleus of the stria terminalis endocannabinoid signaling constrains post-traumatic stress disorder-like behaviors

Article References: Zuo, H., Li, J., Li, J., Zhang, X., & Zhang, B. (2026). The oval bed nucleus of the stria terminalis endocannabinoid signaling constrains post-traumatic stress disorder-like behaviors. Journal of Advanced Research. https://doi.org/10.1016/j.jare.2026.10.015

Image Credits: AI Generated

DOI: 10.1016/j.jare.2026.10.015

Keywords: PTSD, endocannabinoid, ovBNST, bed nucleus of the stria terminalis, CB1 receptor, 2-AG, social defeat stress, pBLA-ovBNST circuit, anxiety, social avoidance, fiber photometry, optogenetics